The epidemiology of Staphylococcus aureus bacteraemia in Israeli children: Community- vs hospital-acquired or healthcare related infections.
Staphylococcus aureus
bacteraemia
community acquired
hospital acquired
paediatric
Journal
Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
14
11
2019
revised:
15
05
2020
accepted:
01
06
2020
pubmed:
9
6
2020
medline:
15
5
2021
entrez:
8
6
2020
Statut:
ppublish
Résumé
Incidences of Staphylococcus aureus bacteraemia (SAB) in Israeli children are unknown. The characteristics of SAB in children have not been evaluated. SAB from children aged ≤18 years old, admitted to a tertiary hospital in Israel during 2002-2015, were included. The proportional rate of SAB was calculated per 1000 admissions. SAB were classified as community acquired (CA), hospital acquired (HA) and healthcare related (HCR). Patients' characteristics, antibiotic susceptibility and outcomes were assessed in each group. The rate of SAB was stable, 1.48 per 1000 admissions. HA, CA and HCR-SAB comprised 53%, 25% and 22%, respectively. Only 27/185 (14.6%) were caused by methicillin-resistant S aureus (MRSA): 22%, 6% and 5% of HA, CA and HCR-SAB, respectively. Central venous catheter, recent surgery, immunodeficiency and age <6 years were the main risk factors for HA and HCR-SAB (adjusted OR: 68.9, 7.5, 5.8 and 5.5, respectively). Treatment duration for CA was >21 days: and for HA and HCR, 14-20 days. All-cause in-hospital mortality and 30-day mortality were documented in 10 (5%) and 3 (2%) episodes, respectively. The rate of SAB; the proportions of CA, HA and HCR-SAB; and the proportion of MRSA was stable over the years. MRSA was mainly in HA-SAB. Thirty-day mortality was rare.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
210-218Informations de copyright
© 2020 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
Références
Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309-317.
Cobos-Carrascosa E, Soler-Palacín P, Nieves Larrosa M, et al. Staphylococcus aureus bacteremia in children changes during eighteen years. Pediatr Infect Dis J. 2015;34(12):1329-1334.
Vanderkoo OG, Gregson DB, Kellner JD, et al. Staphylococcus aureus bloodstream infections in children: a population-based assessment. Paediatr Child Health. 2011;16(5):276-280.
Frederiksen MS, Espersen F, Frimodt-Moller N, et al. Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000. Pediatr Infect Dis J. 2007;26:398-405.
Asgeirsson H, Gudlaugsson O, Kristinsson KG, et al. Low mortality of Staphylococcus aureus bacteremia in Icelandic children: nationwide study on incidence and outcome. Pediatr Infect Dis J. 2015;34(2):140-144.
McMullan BJ, Bowen A, Blyth CC, et al. Epidemiology and mortality of Staphylococcus aureus bacteremia in Australian and New Zealand Children. JAMA Pediatr. 2016;170(10):979-986.
Klieger SB, Vendetti ND, Fisher BT, Gerber JS. Staphylococcus aureus bacteremia in hospitalized children: incidence and outcomes. Infect Control Hosp Epidemiol. 2015;36(5):603.
Turnidge JD, Kotsanas D, Munckhof W, et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust. 2009;191(7):368-373.
Jensen AG, Wachmann CH, Poulsen KB, et al. Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med. 1999;159(13):1437-1444.
Lukovac E, KoluderCimic N, HadzovicCengic M, et al. Analysis of comorbidity of the patients affected by staphylococcal bacteremia/sepsis in the last ten years. Mat Soc Med. 2012;24:13-15.
Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763-1771.
Cardoso T, Mónica Almeida N, Friedman D. Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med. 2014;12:40.
Gordon O, Cohen MJ, Gross I, et al. Staphylococcus aureus Bacteremia in children: antibiotic resistance and mortality. Pediatr Infect Dis J. 2019;38(5):459-463.
Centers for Disease Control and Prevention. https://www.cdc.gov/infectioncontrol/guidelines/bsi/background/terminology.html. Accessed November 05, 2015.
Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis. 2002;34:1431-1439.
McCarthy NL, Sullivan PS, Gaynes R, et al. Health care-associated and community-associated methicillin-resistant Staphylococcus aureus infections: a comparison of definitions. Am J Infect Control. 2010;38(8):600-606.
Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-2984.
Greenhow TL, Hung YY, Herz A. Bacteremia in children 3 to 36 months old after introduction of conjugated pneumococcal vaccines. Pediatrics. 2017;139:e20162098.
Reiss-Mandel A, Regev-Yochay G Staphylococcus aureus and Streptococcus pneumoniae interaction and response to pneumococcal vaccination: myth or reality? Hum Vaccin Immunother. 2016;12(2):351-357.
Naidoo R, Nuttall J, Whitelaw A, et al. Epidemiology of Staphylococcus aureus bacteraemia at a tertiary children's hospital in Cape Town, South Africa. PLoS One. 2013;8(10):78396.
Jensen AG, Wachmann CH, Poulsen KB, et al. Risk factors for hospital-acquired Staphylococcus aureus Bacteremia. Arch Intern Med. 1999;159(13):1437-1444.
Monecke S, Coombs G, Shore AC, et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One. 2011;6(4):e17936.
O'Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev. 2004;17(1):218-234.